FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004352630> ?p ?o ?g. }

• W2004352630 endingPage "e79721" @default.
• W2004352630 startingPage "e79721" @default.
• W2004352630 abstract "High phosphate intake is known to aggravate renal osteodystrophy along various pathogenetic pathways. Recent studies have raised the possibility that dysregulation of the osteocyte Wnt/β-catenin signaling pathway is also involved in chronic kidney disease (CKD)-related bone disease. We investigated the role of dietary phosphate and its possible interaction with this pathway in an experimental model of adynamic bone disease (ABD) in association with CKD and hypoparathyroidism. Partial nephrectomy (Nx) and total parathyroidectomy (PTx) were performed in male Wistar rats. Control rats with normal kidney and parathyroid function underwent sham operations. Rats were divided into three groups and underwent pair-feeding for 8 weeks with diets containing either 0.6% or 1.2% phosphate: sham 0.6%, Nx+PTx 0.6%, and Nx+PTx 1.2%. In the two Nx+PTx groups, serum creatinine increased and blood ionized calcium decreased compared with sham control group. They also presented hyperphosphatemia and reduced serum parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) levels. Fractional urinary excretion of phosphate increased in Nx+PTx 1.2% rats despite lower PTH and FGF23 levels than in sham group. These biochemical changes were accompanied by a decrease in bone formation rates. The Nx+PTx 1.2% group had lower bone volume (BV/TV), higher osteoblast and osteocyte apoptosis, and higher SOST and Dickkopf-1 gene expression than the Nx+PTx 0.6% group. Nx+PTx 0.6% rat had very low serum sclerostin levels, and Nx+PTx 1.2% had intermediate sclerostin levels compared with sham group. Finally, there was a negative correlation between BV/TV and serum sclerostin. These results suggest that high dietary phosphate intake decreases bone volume in an experimental model of CKD-ABD, possibly via changes in SOST expression through a PTH-independent mechanism. These findings could have relevance for the clinical setting of CKD-ABD in patients who low turnover bone disease might be attenuated by optimal control of phosphate intake and/or absorption." @default.
• W2004352630 created "2016-06-24" @default.
• W2004352630 creator A5000305338 @default.
• W2004352630 creator A5003517208 @default.
• W2004352630 creator A5009932201 @default.
• W2004352630 creator A5015906991 @default.
• W2004352630 creator A5022634842 @default.
• W2004352630 creator A5026738407 @default.
• W2004352630 creator A5032326208 @default.
• W2004352630 creator A5042261547 @default.
• W2004352630 creator A5050036172 @default.
• W2004352630 creator A5053045970 @default.
• W2004352630 creator A5073082578 @default.
• W2004352630 creator A5080204588 @default.
• W2004352630 creator A5089493295 @default.
• W2004352630 date "2013-11-13" @default.
• W2004352630 modified "2023-10-11" @default.
• W2004352630 title "Effects of Dietary Phosphate on Adynamic Bone Disease in Rats with Chronic Kidney Disease – Role of Sclerostin?" @default.
• W2004352630 cites W1973274158 @default.
• W2004352630 cites W1982395713 @default.
• W2004352630 cites W1982868568 @default.
• W2004352630 cites W1983133134 @default.
• W2004352630 cites W1987586045 @default.
• W2004352630 cites W2002983094 @default.
• W2004352630 cites W2003391814 @default.
• W2004352630 cites W2011487525 @default.
• W2004352630 cites W2013293643 @default.
• W2004352630 cites W2019582558 @default.
• W2004352630 cites W2021449502 @default.
• W2004352630 cites W2029614230 @default.
• W2004352630 cites W2035689075 @default.
• W2004352630 cites W2038393248 @default.
• W2004352630 cites W2038893356 @default.
• W2004352630 cites W2041242683 @default.
• W2004352630 cites W2061534047 @default.
• W2004352630 cites W2075964058 @default.
• W2004352630 cites W2078883007 @default.
• W2004352630 cites W2080169592 @default.
• W2004352630 cites W2083265178 @default.
• W2004352630 cites W2083586358 @default.
• W2004352630 cites W2087378917 @default.
• W2004352630 cites W2088466503 @default.
• W2004352630 cites W2093796103 @default.
• W2004352630 cites W2117005980 @default.
• W2004352630 cites W2129544443 @default.
• W2004352630 cites W2130776121 @default.
• W2004352630 cites W2145885559 @default.
• W2004352630 cites W2146138547 @default.
• W2004352630 cites W2149719379 @default.
• W2004352630 cites W2159293127 @default.
• W2004352630 cites W2159374159 @default.
• W2004352630 cites W2162733993 @default.
• W2004352630 cites W2163341100 @default.
• W2004352630 cites W2164137478 @default.
• W2004352630 cites W2182230635 @default.
• W2004352630 cites W2342290415 @default.
• W2004352630 cites W4253250895 @default.
• W2004352630 doi "https://doi.org/10.1371/journal.pone.0079721" @default.
• W2004352630 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3827459" @default.
• W2004352630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24236156" @default.
• W2004352630 hasPublicationYear "2013" @default.
• W2004352630 type Work @default.
• W2004352630 sameAs 2004352630 @default.
• W2004352630 citedByCount "47" @default.
• W2004352630 countsByYear W20043526302014 @default.
• W2004352630 countsByYear W20043526302015 @default.
• W2004352630 countsByYear W20043526302016 @default.
• W2004352630 countsByYear W20043526302017 @default.
• W2004352630 countsByYear W20043526302018 @default.
• W2004352630 countsByYear W20043526302019 @default.
• W2004352630 countsByYear W20043526302020 @default.
• W2004352630 countsByYear W20043526302021 @default.
• W2004352630 countsByYear W20043526302022 @default.
• W2004352630 countsByYear W20043526302023 @default.
• W2004352630 crossrefType "journal-article" @default.
• W2004352630 hasAuthorship W2004352630A5000305338 @default.
• W2004352630 hasAuthorship W2004352630A5003517208 @default.
• W2004352630 hasAuthorship W2004352630A5009932201 @default.
• W2004352630 hasAuthorship W2004352630A5015906991 @default.
• W2004352630 hasAuthorship W2004352630A5022634842 @default.
• W2004352630 hasAuthorship W2004352630A5026738407 @default.
• W2004352630 hasAuthorship W2004352630A5032326208 @default.
• W2004352630 hasAuthorship W2004352630A5042261547 @default.
• W2004352630 hasAuthorship W2004352630A5050036172 @default.
• W2004352630 hasAuthorship W2004352630A5053045970 @default.
• W2004352630 hasAuthorship W2004352630A5073082578 @default.
• W2004352630 hasAuthorship W2004352630A5080204588 @default.
• W2004352630 hasAuthorship W2004352630A5089493295 @default.
• W2004352630 hasBestOaLocation W20043526301 @default.
• W2004352630 hasConcept C114276007 @default.
• W2004352630 hasConcept C126322002 @default.
• W2004352630 hasConcept C134018914 @default.
• W2004352630 hasConcept C137620995 @default.
• W2004352630 hasConcept C159641895 @default.
• W2004352630 hasConcept C185592680 @default.
• W2004352630 hasConcept C202751555 @default.
• W2004352630 hasConcept C2776036575 @default.
• W2004352630 hasConcept C2776699218 @default.

• next